Edition:
United Kingdom

People: Ucb SA (UCB.BR)

UCB.BR on Brussels Stock Exchange

75.50EUR
4:35pm BST
Change (% chg)

€1.00 (+1.34%)
Prev Close
€74.50
Open
€74.52
Day's High
€75.50
Day's Low
€74.36
Volume
425,315
Avg. Vol
330,967
52-wk High
€81.48
52-wk Low
€67.36

van Zyl, Charl 

Mr. Charl van Zyl has served as Executive Vice President, Chief Operating Officer, Member of the Executive Committee of UCB S.A. since March 1, 2017. As of 2014, he served as Executive Vice President, Global Commercial Head and Head of Latam/Canada at BSN Medical. From 2009 to 2013 he worked for Bauch & Lomb as Executive Vice President, President of EMEA and from 2007 to 2009 he was Chief Executive Officer of Jado Technologies (Biotech). From 2004 to 2007 he served at Novartis as Head Marketing and Sales EMEA and Head of Global Marketing. Moreover, he was Marketing Manager Diabetes Care and Neurosciences Latam/Canada and South Africa Marketing Manager Japan at Eli Lilly from 1995 to 2004. In 1991 he graduated from University of Cape Town, South Africa in Medical Biochemistry and in 1999 in Business Administration – executive program from the same university.

Basic Compensation

Total Annual Compensation, EUR --
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR 461,607
All Other, EUR --
Fiscal Year Total, EUR 461,607

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --